• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急诊室中一个被遗忘的过敏原因,在资源匮乏地区仍难以诊断和治疗:使用血管紧张素转换酶抑制剂4年后出现的血管性水肿。

A Forgotten Cause of Allergy at ER That Is Still Difficult to Diagnose and Treat at Poor Resource Setting: Angioedema after Using Angiotensin Converting Enzyme Inhibitors for 4 Years.

作者信息

Nishad A A Nilanga, Arulmoly K, Priyankara S A S, Abeysundara P K

机构信息

Teaching Hospital, Batticaloa, Sri Lanka.

North Colombo Teaching Hospital, Ragama, Sri Lanka.

出版信息

Case Reports Immunol. 2019 Jan 2;2019:1676391. doi: 10.1155/2019/1676391. eCollection 2019.

DOI:10.1155/2019/1676391
PMID:30723559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6339731/
Abstract

Angiotensin converting enzyme inhibitors (ACEi) are the most commonly used antihypertensives. Therefore, ACEI induced angioedema (ACEi-AE) is not uncommon. Physicians tend to miss the diagnosis whenever a patient is taking the drug for years due to misbelief of "a drug that was taken for years may not be the cause for an allergic reaction or an angioedema". But ACEi can induce angioedema after many years of usage as well as sometimes after stopping the drug even. Most of the emergency physicians and centers are not aware of clinical diagnosis and diagnostic criteria including available diagnostic tests and more importantly the treatment options of ACEi-AE. Therefore not only the diagnosis is delayed or missing but also proper treatment options are not practiced at many emergency rooms and at wards.

摘要

血管紧张素转换酶抑制剂(ACEi)是最常用的抗高血压药物。因此,ACEi诱发的血管性水肿(ACEi-AE)并不罕见。由于存在“服用多年的药物可能不是过敏反应或血管性水肿的原因”这种错误观念,每当患者服用该药物多年时,医生往往会漏诊。但ACEi在使用多年后以及有时甚至在停药后都可能诱发血管性水肿。大多数急诊医生和急救中心并不了解ACEi-AE的临床诊断和诊断标准,包括可用的诊断测试,更重要的是其治疗选择。因此,不仅诊断会延迟或漏诊,而且许多急诊室和病房也没有采用适当的治疗方案。

相似文献

1
A Forgotten Cause of Allergy at ER That Is Still Difficult to Diagnose and Treat at Poor Resource Setting: Angioedema after Using Angiotensin Converting Enzyme Inhibitors for 4 Years.急诊室中一个被遗忘的过敏原因,在资源匮乏地区仍难以诊断和治疗:使用血管紧张素转换酶抑制剂4年后出现的血管性水肿。
Case Reports Immunol. 2019 Jan 2;2019:1676391. doi: 10.1155/2019/1676391. eCollection 2019.
2
Angiotensin-converting enzyme inhibitors as a cause of isolated angioedema in a Slovenian population.血管紧张素转换酶抑制剂作为斯洛文尼亚人群中孤立性血管性水肿的一个病因。
Acta Dermatovenerol Alp Pannonica Adriat. 2016;25(1):1-4. doi: 10.15570/actaapa.2016.1.
3
Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria.血管紧张素转换酶抑制剂(ACEI)诱发血管性水肿研究者评定量表的开发与验证及拟议的出院标准
BMC Health Serv Res. 2017 May 22;17(1):366. doi: 10.1186/s12913-017-2274-4.
4
Acquired angioedema induced by angiotensin-converting enzyme inhibitors - experience of a hospital-based allergy center.血管紧张素转换酶抑制剂诱发的获得性血管性水肿——一家医院过敏中心的经验
Exp Ther Med. 2020 Jul;20(1):68-72. doi: 10.3892/etm.2020.8474. Epub 2020 Jan 27.
5
Angioedema: etiology, pathophysiology, current and emerging therapies.血管性水肿:病因、病理生理学、现有及新出现的治疗方法。
J Emerg Med. 2013 Nov;45(5):789-96. doi: 10.1016/j.jemermed.2013.03.045. Epub 2013 Aug 29.
6
[Increasing incidence of angioedema without urticaria--clinical features].[无荨麻疹的血管性水肿发病率增加——临床特征]
Acta Med Croatica. 2011;65(2):119-27.
7
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Case Report With a Review of Management Options.血管紧张素转换酶抑制剂诱发的血管性水肿:一例报告及治疗选择综述
Cureus. 2023 Jun 12;15(6):e40320. doi: 10.7759/cureus.40320. eCollection 2023 Jun.
8
Hypovolemic Shock Caused by Angiotensin-Converting Enzyme Inhibitor-Induced Visceral Angioedema: A Case Series and A Simple Method to Diagnose this Complication in the Emergency Department.血管紧张素转换酶抑制剂诱发的内脏血管性水肿所致低血容量性休克:病例系列及急诊科诊断这一并发症的简易方法
J Emerg Med. 2018 Mar;54(3):375-379. doi: 10.1016/j.jemermed.2017.12.009.
9
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema Following Posterior Reversible Encephalopathy Syndrome in a Child: A Case Report.一名儿童发生后部可逆性脑病综合征后出现血管紧张素转换酶抑制剂诱发的血管性水肿:病例报告
Cureus. 2022 Nov 16;14(11):e31568. doi: 10.7759/cureus.31568. eCollection 2022 Nov.
10
Effect of icatibant on angiotensin-converting enzyme inhibitor-induced angioedema: A meta-analysis of randomized controlled trials.依卡替班对血管紧张素转化酶抑制剂诱导血管性水肿的影响:一项随机对照试验的荟萃分析。
J Clin Pharm Ther. 2019 Oct;44(5):685-692. doi: 10.1111/jcpt.12997. Epub 2019 Jul 9.

引用本文的文献

1
Urticarial eruption in coronavirus disease 2019 infection: a case report in Tangerang, Indonesia.2019冠状病毒病感染中的荨麻疹样皮疹:印度尼西亚丹格朗的一例病例报告。
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e372-e373. doi: 10.1111/jdv.16622. Epub 2020 Jun 4.

本文引用的文献

1
Endogenous bradykinin and B1-B5 during angiotensin-converting enzyme inhibitor-associated angioedema.血管紧张素转化酶抑制剂相关性血管水肿期间的内源性缓激肽和 B1-B5。
J Allergy Clin Immunol. 2018 Nov;142(5):1636-1639.e5. doi: 10.1016/j.jaci.2018.06.037. Epub 2018 Jul 21.
2
Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.缓激肽介导的血管性水肿的流行病学:对流行病学研究的系统调查。
Orphanet J Rare Dis. 2018 May 4;13(1):73. doi: 10.1186/s13023-018-0815-5.
3
Angiotensin-converting Enzyme Inhibitor and Other Drug-associated Angioedema.
血管紧张素转换酶抑制剂及其他药物相关的血管性水肿
Immunol Allergy Clin North Am. 2017 Aug;37(3):483-495. doi: 10.1016/j.iac.2017.04.006.
4
Angioedema in the emergency department: a practical guide to differential diagnosis and management.急诊科血管性水肿:鉴别诊断与管理实用指南
Int J Emerg Med. 2017 Dec;10(1):15. doi: 10.1186/s12245-017-0141-z. Epub 2017 Apr 13.
5
Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record.利用大型电子健康记录研究血管紧张素转换酶抑制剂所致血管性水肿的流行病学
J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):744-749. doi: 10.1016/j.jaip.2017.02.018. Epub 2017 Apr 1.
6
Determinants of angiotensin-converting enzyme inhibitor (ACEI) intolerance and angioedema in the UK Clinical Practice Research Datalink.英国临床实践研究数据链中血管紧张素转换酶抑制剂(ACEI)不耐受和血管性水肿的决定因素
Br J Clin Pharmacol. 2016 Dec;82(6):1647-1659. doi: 10.1111/bcp.13090. Epub 2016 Oct 4.
7
The Use of Plasma-Derived Complement C1-Esterase Inhibitor Concentrate (Berinert®) in the Treatment of Angiotensin Converting Enzyme-Inhibitor Related Angioedema.血浆源性补体C1酯酶抑制剂浓缩物(百林妥®)在治疗血管紧张素转换酶抑制剂相关血管性水肿中的应用
Case Rep Emerg Med. 2016;2016:3930923. doi: 10.1155/2016/3930923. Epub 2016 Mar 31.
8
Life threatening angioedema in a patient on ACE inhibitor (ACEI) confined to the upper airway.一名服用血管紧张素转换酶抑制剂(ACEI)的患者出现危及生命的血管性水肿,且局限于上呼吸道。
Qatar Med J. 2014 Dec 9;2014(2):92-7. doi: 10.5339/qmj.2014.15. eCollection 2014.
9
A randomized trial of icatibant in ACE-inhibitor-induced angioedema.依替巴肽治疗血管性水肿的随机试验。
N Engl J Med. 2015 Jan 29;372(5):418-25. doi: 10.1056/NEJMoa1312524.
10
Ecallantide for the acute treatment of angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter, randomized, controlled trial.依替巴肽治疗血管紧张素转换酶抑制剂诱导的血管性水肿的急性治疗:一项多中心、随机、对照试验。
Ann Emerg Med. 2015 Feb;65(2):204-13. doi: 10.1016/j.annemergmed.2014.07.014. Epub 2014 Aug 30.